Migraine Treatment Market Poised for 11 % Growth, Set to Hit $5.32 Billion by 2029

What industry-specific factors are fueling the growth of the migraine treatment market?
The continuous interaction with electronic screens, known as prolonged screen exposure, is anticipated to drive the growth of the migraine treatment market. This includes exposure to screens such as smartphones, tablets, computers, and televisions. The contribution to longer screen times is due to factors like the rise in remote work, online education, digital entertainment, and an increasing dependency on technology for social engagements. Managing migraine symptoms triggered or aggravated by this extended screen interaction, involves methods such as medication intakes, lifestyle changes, and adherence to ergonomic principles to reduce strain and avert episodes. For example, a report from the House of Commons Committee, a health organization based in the UK Parliament, reported in May 2024 that children's screen time rose by 52% in 2022. Almost 25% of children and adolescents displayed smartphone usage patterns characteristic of behavioral addiction. Consequently, such extensive screen exposure is propelling the growth of the migraine treatment market.

Get Your Migraine Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

What Is the projected market size and growth rate for the migraine treatment market?
There has been significant growth in the migraine treatment market in the past few years. The market, which is projected to increase from $3.18 billion in 2024 to $3.48 billion in 2025, is expected to experience a compound annual growth rate (CAGR) of 9.4%. This impressive growth during the historic period is a result of several factors including a higher incidence of migraines, increased spending on healthcare, enhancements to existing drug formulas, growth in clinical research, and the development of new treatment methods.

The market size for migraine treatments is forecasted to experience substantial growth in the coming years, escalating to $5.32 billion in 2029 with a compound annual growth rate (CAGR) of 11.2%. This growth over the forecast period is expected to be driven by factors such as increasing awareness and education, the introduction of monoclonal antibodies, amplified attention towards pediatric migraines, proliferation of non-pharmacological interventions, global efforts towards migraine research. The forecast period is also likely to see notable trends such as progress in therapeutic strategies, utilization of wearable devices and digital therapeutics, uptake of telemedicine and remote consultations, an emphasis on patient-centric care models, growth in the generic drug market, and the use of oral CGRP inhibitors.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8126&type=smp

What new trends are reshaping the migraine treatment market and its opportunities?
A key trend emerging in the migraine treatment market is the emphasis on product innovations. Leading companies in the industry are unveiling innovative products like liquid formulations to consolidate their market stand. BioDelivery Sciences International (BDSI), an American pharmaceutical firm, is a case in point. In January 2022, it debuted its new product, Elyxyb (celecoxib oral solution), intended to treat acute migraines in adults irrespective of their aura manifestation. Elyxyb's liquid formulation ensures swift absorption in the small intestine, providing quicker relief than conventional tablet forms. This is particularly useful for migraine patients dealing with nausea or vomiting as it does away with the need for a pill to dissolve. Elyxyb, being the first and only FDA-approved ready-to-use oral solution for migraines, offers a more manageable and effective treatment alternative for handling the severe pain affiliated with migraines.

What major market segments define the scope and growth of the migraine treatment market?
The migraine treatment market covered in this report is segmented -

1) By Types: Episodic, Migraine With Aura, Chronic, Other Types
2) By Treatment: Acute Or Abortive Treatment, Preventive Or prophylactic Treatment, Non-Pharmacological Therapies And Devices
3) By End-User: Hospitals, Clinics, Homecare, Other End-users

Subsegments:
1) By Episodic: Frequent Episodic Migraine, Infrequent Episodic Migraine
2) By Migraine With Aura: Visual Aura, Sensory Aura, Speech Or Language Aura
3) By Chronic: Chronic Migraine Without Aura, Chronic Migraine With Aura
4) By Other Types: Hemiplegic Migraine, Retinal Migraine, Menstrual Migraine, Other Specific Types

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8126

Which region dominates the migraine treatment market?
North America was the largest region in the migraine treatment market in 2024. The regions covered in the migraine treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the migraine treatment industry growth?
Major companies operating in the migraine treatment market are Pfizer Inc., Eli Lilly and Company, Amgen Inc., GlaxoSmithKline PLC, Novartis AG, Bayer AG, Allergan PLC, Abbott Laboratories, Allodynic Therapeutics LLC, AOBiome LLC, AstraZeneca PLC, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Limited, Impel Pharmaceuticals Inc., AbbVie Inc., Alder BioPharmaceuticals Inc., Astellas Pharma Inc., Biohaven Pharmaceutical Holding Company Ltd., Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Endo International PLC, Impax Laboratories Inc., Johnson & Johnson Inc., Lannett Company Inc., Lupin Limited, Merck & Co. Inc., Mylan N.V.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8126&type=smp

What Is Covered In The Migraine Treatment Global Market Report?

• Market Size Forecast: Examine the migraine treatment market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the migraine treatment market for a structured understanding.
• Key Players Overview: Analyze major players in the migraine treatment market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the migraine treatment market.
• Segment Contributions: Evaluate how different segments drive overall growth in the migraine treatment market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the migraine treatment market.
• Industry Challenges: Identify potential risks and obstacles affecting the migraine treatment market.
• Competitive Landscape: Review strategic developments in the migraine treatment market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.